US Patent 11345751 FcRn antibodies and methods of use thereof
Patent 11345751 was granted and assigned to Momenta Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 31, 2017
0
Date of Patent
May 31, 2022
0
Patent Applicant
Patent Application Number
16321801
0
Patent Citations
Patent Citations Received
Patent Inventor Names
Leona E. Ling
0
Sucharita Roy
0
Nathaniel Washburn
0
Anthony Manning
0
David J. King
0
James Meador, III
0
Jan Hillson
0
Marilyn Kehry
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11345751 FcRn antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
